413 related articles for article (PubMed ID: 27615139)
1. Pancreatic β-cell identity in diabetes.
Remedi MS; Emfinger C
Diabetes Obes Metab; 2016 Sep; 18 Suppl 1(Suppl 1):110-6. PubMed ID: 27615139
[TBL] [Abstract][Full Text] [Related]
2. β-Cell dysfunction in diabetes: a crisis of identity?
Brereton MF; Rohm M; Ashcroft FM
Diabetes Obes Metab; 2016 Sep; 18 Suppl 1(Suppl 1):102-9. PubMed ID: 27615138
[TBL] [Abstract][Full Text] [Related]
3. Transcriptional control of pancreatic β-cell identity and plasticity during the pathogenesis of type 2 diabetes.
Zhang Z; Gao Y; Meng ZX
J Genet Genomics; 2022 Apr; 49(4):316-328. PubMed ID: 35292418
[TBL] [Abstract][Full Text] [Related]
4. β-Cell Fate in Human Insulin Resistance and Type 2 Diabetes: A Perspective on Islet Plasticity.
Mezza T; Cinti F; Cefalo CMA; Pontecorvi A; Kulkarni RN; Giaccari A
Diabetes; 2019 Jun; 68(6):1121-1129. PubMed ID: 31109941
[TBL] [Abstract][Full Text] [Related]
5. Diabetes recovery by age-dependent conversion of pancreatic δ-cells into insulin producers.
Chera S; Baronnier D; Ghila L; Cigliola V; Jensen JN; Gu G; Furuyama K; Thorel F; Gribble FM; Reimann F; Herrera PL
Nature; 2014 Oct; 514(7523):503-7. PubMed ID: 25141178
[TBL] [Abstract][Full Text] [Related]
6. Stress-induced adaptive islet cell identity changes.
Cigliola V; Thorel F; Chera S; Herrera PL
Diabetes Obes Metab; 2016 Sep; 18 Suppl 1(Suppl 1):87-96. PubMed ID: 27615136
[TBL] [Abstract][Full Text] [Related]
7. Loss of β-cell identity and dedifferentiation, not an irreversible process?
Patel S; Remedi MS
Front Endocrinol (Lausanne); 2024; 15():1414447. PubMed ID: 38915897
[TBL] [Abstract][Full Text] [Related]
8. Systematic single-cell analysis provides new insights into heterogeneity and plasticity of the pancreas.
Tritschler S; Theis FJ; Lickert H; Böttcher A
Mol Metab; 2017 Sep; 6(9):974-990. PubMed ID: 28951822
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms of adult human β-cell in vitro dedifferentiation and redifferentiation.
Efrat S
Diabetes Obes Metab; 2016 Sep; 18 Suppl 1():97-101. PubMed ID: 27615137
[TBL] [Abstract][Full Text] [Related]
10. Klf6 protects β-cells against insulin resistance-induced dedifferentiation.
Dumayne C; Tarussio D; Sanchez-Archidona AR; Picard A; Basco D; Berney XP; Ibberson M; Thorens B
Mol Metab; 2020 May; 35():100958. PubMed ID: 32244185
[TBL] [Abstract][Full Text] [Related]
11. Pancreatic islet cell plasticity: Pathogenic or therapeutically exploitable?
Tanday N; Tarasov AI; Moffett RC; Flatt PR; Irwin N
Diabetes Obes Metab; 2024 Jan; 26(1):16-31. PubMed ID: 37845573
[TBL] [Abstract][Full Text] [Related]
12. The undoing and redoing of the diabetic β-cell.
Wang W; Liu C; Jimenez-Gonzalez M; Song WJ; Hussain MA
J Diabetes Complications; 2017 May; 31(5):912-917. PubMed ID: 28242267
[TBL] [Abstract][Full Text] [Related]
13. XBP1 maintains beta cell identity, represses beta-to-alpha cell transdifferentiation and protects against diabetic beta cell failure during metabolic stress in mice.
Lee K; Chan JY; Liang C; Ip CK; Shi YC; Herzog H; Hughes WE; Bensellam M; Delghingaro-Augusto V; Koina ME; Nolan CJ; Laybutt DR
Diabetologia; 2022 Jun; 65(6):984-996. PubMed ID: 35316840
[TBL] [Abstract][Full Text] [Related]
14. Update on the transdifferentiation of pancreatic cells into functional beta cells for treating diabetes.
Spezani R; Reis-Barbosa PH; Mandarim-de-Lacerda CA
Life Sci; 2024 Jun; 346():122645. PubMed ID: 38614297
[TBL] [Abstract][Full Text] [Related]
15. Alterations in Beta Cell Identity in Type 1 and Type 2 Diabetes.
Moin ASM; Butler AE
Curr Diab Rep; 2019 Aug; 19(9):83. PubMed ID: 31401713
[TBL] [Abstract][Full Text] [Related]
16. Pancreatic β-cell failure, clinical implications, and therapeutic strategies in type 2 diabetes.
Cui D; Feng X; Lei S; Zhang H; Hu W; Yang S; Yu X; Su Z
Chin Med J (Engl); 2024 Apr; 137(7):791-805. PubMed ID: 38479993
[TBL] [Abstract][Full Text] [Related]
17. β-Cell Maturation and Identity in Health and Disease.
Salinno C; Cota P; Bastidas-Ponce A; Tarquis-Medina M; Lickert H; Bakhti M
Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31671683
[TBL] [Abstract][Full Text] [Related]
18. Insulin Action Research and the Future of Diabetes Treatment: The 2017 Banting Medal for Scientific Achievement Lecture.
Accili D
Diabetes; 2018 Sep; 67(9):1701-1709. PubMed ID: 30135131
[TBL] [Abstract][Full Text] [Related]
19. Improving glycaemic control in type 2 diabetes: Stimulate insulin secretion or provide beta-cell rest?
van Raalte DH; Verchere CB
Diabetes Obes Metab; 2017 Sep; 19(9):1205-1213. PubMed ID: 28295962
[TBL] [Abstract][Full Text] [Related]
20. Chronic antidiabetic sulfonylureas in vivo: reversible effects on mouse pancreatic beta-cells.
Remedi MS; Nichols CG
PLoS Med; 2008 Oct; 5(10):e206. PubMed ID: 18959471
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
